Travere Therapeutics, Inc. Common Stock (TVTX)
Travere Therapeutics faces FDA information request on FILSPARI efficacy, causing price drops despite analyst upgrades. Regulatory uncertainty is driving negative market reaction.
About Travere Therapeutics, Inc. Common Stock
Travere Therapeutics, Inc. is a pharmaceutical company focused on developing therapies for rare diseases.
Travere Therapeutics, Inc. Common Stock uses the ticker $TVTX for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Travere Therapeutics, Inc. Common Stock (TVTX) social dominance is up 101.61% from the previous week.
- Travere Therapeutics, Inc. Common Stock (TVTX) creators is up 51.43% from the previous week.
- Travere Therapeutics, Inc. Common Stock (TVTX) engagements is up 15.56% from the previous week.
- Travere Therapeutics, Inc. Common Stock (TVTX) mentions is up 39.13% from the previous week.
- Travere Therapeutics, Inc. Common Stock (TVTX) posts created is up 20% from the previous week.
Price: $27.80
Price 24-Hour Time-Series Raw Data
The stock is experiencing negative price action due to an FDA information request concerning FILSPARI's efficacy, leading to price drops despite some analyst upgrades. Regulatory uncertainty is driving negative market reaction.
24-Hour: -9.08% 7-Day: -5.44% 30-Day: -0.18%
1-Year High: $40.30 on 2025-12-24
1-Year Low: $13.50 on 2025-04-10
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Travere Therapeutics, Inc. Common Stock (TVTX) is currently AltRank #1,170 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +108
[--] Months: [---] +121
[--] Year: [---] +392
1-Year High: [-----] on 2026-01-26
1-Year Low: [--] on 2025-11-22
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
1-Year High: [--] on 2025-12-29
1-Year Low: [--] on 2025-11-21
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] +16%
[--] Month: [-------] -75%
[--] Months: [---------] +135%
[--] Year: [---------] +106%
1-Year High: [-------] on 2025-05-01
1-Year Low: [---] on 2026-02-16
Engagements by network (24h): News: [--] YouTube: [--] X: [-----] Reddit: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +39%
[--] Month: [---] -6.90%
[--] Months: [-----] +102%
[--] Year: [-----] +265%
1-Year High: [---] on 2026-01-15
1-Year Low: [--] on 2025-04-13
Mentions by network (24h): News: [--] YouTube: [--] X: [--] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Travere Therapeutics, Inc. Common Stock (TVTX) in the last [--] hours which is down 20% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +51%
[--] Month: [---] -8%
[--] Months: [-----] +16%
[--] Year: [-----] +319%
1-Year High: [---] on 2026-01-15
1-Year Low: [--] on 2025-04-18
The most influential creators that mention Travere Therapeutics, Inc. Common Stock in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Maximus_Holla | [--] | [------] | [--] | [-----] |
| @Andre_AGTC | [--] | [-----] | [--] | [---] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @Stella63592 | [--] | [--] | [--] | [--] |
| @BiopharmIQ | [--] | [------] | [--] | [--] |
| @NightOwlBiotech | [--] | [-----] | [--] | [--] |
| @CameronBoswell8 | [--] | [---] | [--] | [--] |
| @mariostario2019 | [--] | [--] | [--] | [--] |
| @raheelmohmmed1 | [--] | [---] | [--] | [--] |
| @RebellioMarket | [--] | [-------] | [--] | [--] |
Sentiment: 75%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 75%
Daily Average: 88%
[--] Week: 100% no change
[--] Month: 100% +45%
[--] Months: 100% no change
[--] Year: 100% +30%
1-Year High: 100% on 2025-02-21
1-Year Low: 35% on 2025-12-16
Most Supportive Themes:
- FDA Approval/Positive News: (45%) Positive sentiment surrounding the FDA's actions regarding the drug Filspari.
- Analyst Upgrades and Price Target Increases: (25%) Multiple analysts have upgraded Travere Therapeutics ($TVTX), increasing price targets and expressing positive outlooks.
- Strong Performance and Momentum: (20%) Posts highlight $TVTX as a top gainer, with significant price increases and mentions in various stock lists.
Most Critical Themes:
- Losses and Negative Sentiment: (5%) Some posts mention $TVTX as a loser or highlight negative aspects.
Social Dominance: 0.00657%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00657%
Daily Average: 0.00999%
[--] Week: 0.00625% +0.00315%
[--] Month: 0.0099% -0.036%
[--] Months: 0.0099% +0.0016%
[--] Year: 0.0099% -0.0086%
1-Year High: 0.052% on 2026-01-15
1-Year Low: 0.0023% on 2025-04-18
Market Dominance: 0.00282%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00282%
Daily Average: 0%
1-Year High: 0.123% on 2026-02-06
1-Year Low: 0.00282% on 2026-02-16
Market Cap: $2,489,120,137
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,489,120,137
Daily Average: $2,975,905,986
[--] Week: $2,506,119,879 -4.80%
[--] Month: $2,489,120,137 -0.18%
1-Year High: $3,603,945,332 on 2025-12-24
1-Year Low: $2,458,699,546 on 2025-10-22
Top Travere Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Reduced and will revisit later $TVTX [--] break to Gap fill https://t.co/ezkltOWFLC $TVTX [--] break to Gap fill https://t.co/ezkltOWFLC"
X Link @Maximus_Holla 2026-02-13T20:56Z 55.7K followers, [----] engagements
"My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $BLTE NDA STGD1 H1 My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3"
X Link @Andre_AGTC 2026-02-12T14:13Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing